Form 4: Heartflow Officer Reports Equity Grants and Conversions

Heartflow's Chief Accounting Officer, Marie L. Jones, reported the acquisition of restricted stock units, stock options, and the conversion of promissory notes into common stock.

Summary

• Marie L. Jones, Chief Accounting Officer and VP of Heartflow, Inc., reported several equity transactions.
• On August 7, 2025, she acquired 3,618 Restricted Stock Units (RSUs) with a vesting commencement date of August 7, 2025. These RSUs will vest quarterly over 16 quarters.
• On August 11, 2025, 6,578 convertible promissory notes were converted into shares of Heartflow's common stock. This conversion occurred automatically upon the closing of Heartflow's initial public offering at a conversion price of 80% of the IPO price, subject to a $2.0 billion valuation ceiling.
• On March 13, 2025, she acquired 68,492 stock options with an exercise price of $12.68. These options will vest 1/4th on January 8, 2026, and the remainder monthly until January 8, 2029, expiring on March 13, 2035.
• On August 7, 2025, she acquired 19,014 stock options with an exercise price of $19. These options vest 1/48th on each monthly anniversary of the vesting commencement date, expiring on August 7, 2035.
• Following these transactions, Marie L. Jones beneficially owns 10,196 shares of common stock directly, 68,492 stock options directly, and 19,014 stock options directly.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of insider equity transactions, reflecting standard compensation practices and pre-planned conversions. It contains no information that would significantly alter the company's perceived value or outlook, thus maintaining a neutral sentiment.

Positives

• The acquisition of Restricted Stock Units (RSUs) and stock options indicates continued alignment of management's interests with shareholder value through long-term incentive compensation.
• The conversion of convertible promissory notes into common stock upon IPO closing demonstrates a pre-planned event related to the company's public listing.

Negatives

• No inherently negative transactions were reported in this Form 4 filing.

Risks

• No specific risks were mentioned in this Form 4 filing.

Future Outlook

The filing details future vesting schedules for restricted stock units and stock options, indicating a long-term incentive structure for the reporting person extending through 2029 and 2035, respectively.

Industry Context

This Form 4 filing is a standard disclosure of insider equity transactions, reflecting the compensation structure for a key executive. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• This Form 4 filing details individual executive compensation transactions and does not provide information suitable for comparison to global industry benchmarks or specific comparable companies/projects.

Stakeholder Impact

• Shareholders: The grants of RSUs and stock options align the Chief Accounting Officer's interests with long-term shareholder value. The conversion of promissory notes into common stock increases the outstanding share count.
• Employees: The compensation structure for a key executive may reflect broader compensation practices within the company.

Next Steps

• Continued vesting of 3,618 Restricted Stock Units on a quarterly basis from August 7, 2025.
• Continued vesting of 68,492 stock options, with 1/4th vesting on January 8, 2026, and the remainder monthly until January 8, 2029.
• Continued vesting of 19,014 stock options on a monthly basis from August 7, 2025.

Key Dates

Keywords

Heartflow, HTFL, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Convertible Notes, Equity Compensation, Marie L. Jones, Chief Accounting Officer